keyword
https://read.qxmd.com/read/38340168/mesenchymal-stromal-cells-mscs-as-a-therapeutic-agent-of-inflammatory-disease-and-infectious-covid-19-virus-live-or-dead-mesenchymal
#21
REVIEW
Ramiar Kamal Kheder, Omeed Darweesh, Bashdar Mahmud Hussen, Snur Rasool Abdullah, Abbas Basiri, Mohammad Taheri
The COVID-19 infection is a worldwide disease that causes numerous immune-inflammatory disorders, tissue damage, and lung dysfunction. COVID-19 vaccines, including those from Pfizer, AstraZeneca, and Sinopharm, are available globally as effective interventions for combating the disease. The severity of COVID-19 can be most effectively reduced by mesenchymal stromal cells (MSCs) because they possess anti-inflammatory activity and can reverse lung dysfunction. MSCs can be harvested from various sources, such as adipose tissue, bone marrow, peripheral blood, inner organs, and neonatal tissues...
February 10, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38318526/targeting-t-regulatory-t-reg-cells-in-immunotherapy-resistant-cancers
#22
REVIEW
Pavlina Spiliopoulou, Paramjit Kaur, Tracey Hammett, Giusy Di Conza, Michael Lahn
Primary or secondary (i.e., acquired) resistance is a common occurrence in cancer patients and is often associated with high numbers of T regulatory (Treg ) cells (CD4+ CD25+ FOXP3+ ). The approval of ipilimumab and the development of similar pharmacological agents targeting cell surface proteins on Treg cells demonstrates that such intervention may overcome resistance in cancer patients. Hence, the clinical development and subsequent approval of Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) targeting agents can serve as a prototype for similar agents...
2024: Cancer Drug Resistance
https://read.qxmd.com/read/38301363/microcellular-approach-for-the-pathogenesis-of-placenta-accreta-spectrum-inflammatory-versus-apoptotic-pathways-a-thorough-look-on-treg-dnk-and-vegf
#23
JOURNAL ARTICLE
Shereen AbdelFattah, Medhat Morsy, Ahmed Mahmoud Ahmed, Haitham Abdelsalam, Gamal Hosny
Placenta accreta spectrum (PAS) is a disorder of irregular placental invasion to the surrounding structures, it is a leading cause of maternal morbidity and mortality. This study was theorized to perceive the role of Treg cells and VEGF which appealed to play a role in the pathogenesis of nonstandard extreme placental invasion. The study was carried out on 40 pregnant women; Group I (control group), and Group II (placenta accrete spectrum PAS). Light microscopic, immune-histochemical; CD 56 (NK CELLS) and CD 45 RO (T reg) western blot; P53 and VEGF morphometry and statistical analysis were done...
January 26, 2024: Pathology, Research and Practice
https://read.qxmd.com/read/38223058/flow-augmentation-sta-mca-bypass-for-acute-and-subacute-ischemic-stroke-due-to-internal-carotid-artery-occlusion-and-the-role-of-advanced-neuroimaging-with-hemodynamic-and-flow-measurement-in-the-decision-making-preliminary-data
#24
JOURNAL ARTICLE
Martina Sebök, Lara Maria Höbner, Jorn Fierstra, Tilman Schubert, Susanne Wegener, Zsolt Kulcsár, Andreas R Luft, Luca Regli, Giuseppe Esposito
BACKGROUND: A major clinical challenge is the adequate identification of patients with acute (<1 week) and subacute (1-6 weeks) ischemic stroke due to internal carotid artery (ICA) occlusion who could benefit from a surgical revascularization after a failure of endovascular and/or medical treatment. Recently, two novel quantitative imaging modalities have been introduced: (I) quantitative magnetic resonance angiography (qMRA) with non-invasive optimal vessel analysis (NOVA) for quantification of blood flow in major cerebral arteries (in mL/min), and (II) blood oxygenation level-dependent (BOLD) functional magnetic resonance imaging to assess cerebrovascular reactivity (CVR)...
January 3, 2024: Quantitative Imaging in Medicine and Surgery
https://read.qxmd.com/read/38195663/the-feasibility-and-acceptability-of-a-rewards-system-based-on-food-purchasing-behaviour-in-secondary-school-cashless-canteens-the-eat4treats-e4t-cluster-feasibility-non-randomised-controlled-intervention-study
#25
JOURNAL ARTICLE
Sarah E Moore, Ciara Rooney, Charlotte E Neville, Ryan McConville, Frank Kee, Claire T McEvoy, Jayne V Woodside, Judith Hanvey, Michelle C McKinley
BACKGROUND: Using rewards may be an effective method to positively influence children's eating behaviour but evidence to date is limited, particularly in older children. The cashless canteen systems in schools provides a unique opportunity to implement a food-based reward scheme but intervention development work and feasibility testing is needed. The overall aim of the E4T feasibility study was to examine the feasibility and acceptability of implementing a rewards scheme based on the food purchasing behaviour of pupils in cashless canteens in secondary schools...
January 9, 2024: Pilot and Feasibility Studies
https://read.qxmd.com/read/38177096/15-lipoxygenase-promotes-resolution-of-inflammation-in-lymphedema-by-controlling-t-reg-cell-function-through-ifn-%C3%AE
#26
JOURNAL ARTICLE
A Zamora, M Nougué, L Verdu, E Balzan, T Draia-Nicolau, E Benuzzi, F Pujol, V Baillif, E Lacazette, F Morfoisse, J Galitzky, A Bouloumié, M Dubourdeau, B Chaput, N Fazilleau, J Malloizel-Delaunay, A Bura-Rivière, A C Prats, B Garmy-Susini
Lymphedema (LD) is characterized by the accumulation of interstitial fluid, lipids and inflammatory cell infiltrate in the limb. Here, we find that LD tissues from women who developed LD after breast cancer exhibit an inflamed gene expression profile. Lipidomic analysis reveals decrease in specialized pro-resolving mediators (SPM) generated by the 15-lipoxygenase (15-LO) in LD. In mice, the loss of SPM is associated with an increase in apoptotic regulatory T (Treg ) cell number. In addition, the selective depletion of 15-LO in the lymphatic endothelium induces an aggravation of LD that can be rescued by Treg cell adoptive transfer or ALOX15-expressing lentivector injections...
January 4, 2024: Nature Communications
https://read.qxmd.com/read/38156584/-screening-of-antiviral-activity-of-samples-from-chaga-inonotus-obliquus-and-humic-acid-from-brown-coal-on-vero-cell-culture-against-ectromelia-virus-poxviridae-orthopoxvirus-ectv
#27
JOURNAL ARTICLE
T V Teplyakova, A S Kabanov, A S Ovchinnikova, D A Odnoshevskyh, I F Petrovskaya, T S Nepomnyashchikh, O V Pyankov
INTRODUCTION: The mouse-specific orthopoxvirus, ectromelia virus, is one of the best models that can be used to study key issues of pathogenesis, prevention, and treatment of smallpox, and to develop measures to increase virulence, transmissibility, or the ability to overcome vaccine immunity. The aim of the work is to screen the antiviral activity of samples from Inonotus obliquus chaga and humic acid from brown coal in vitro against ectromelia virus. MATERIALS AND METHODS: We used ectromelia virus, strain K-1 (reg...
September 21, 2023: Voprosy Virusologii
https://read.qxmd.com/read/38153634/chimeric-antigen-receptor-car-based-cell-therapy-for-type-1-diabetes-mellitus-t1dm-current-progress-and-future-approaches
#28
REVIEW
Vahid Mohammadi, Armin Jahani Maleki, Mahdis Nazari, Amir Siahmansouri, Amirhosein Moradi, Reza Elahi, Abdolreza Esmaeilzadeh
Type 1 diabetes mellitus (T1DM) is an autoimmune disease that destroys insulin-producing pancreatic β-cells. Insulin replacement therapy is currently the mainstay of treatment for T1DM; however, treatment with insulin does not ameliorate disease progression, as dysregulated immune response and inflammation continue to cause further pancreatic β-cell degradation. Therefore, shifting therapeutic strategies toward immunomodulating approaches could be effective to prevent and reverse disease progression...
December 28, 2023: Stem cell reviews and reports
https://read.qxmd.com/read/38151996/immunoprotective-effect-and-mechanism-of-reg-p29-against-cd4-t-cell-deficient-mice-with-echinococcus-multilocularis-infection
#29
JOURNAL ARTICLE
Ming Li, Yazhou Zhu, Zihua Li, Jiahui Song, Wei Zhao
Alveolar echinococcosis (AE) is a zoonotic parasitic disease caused by infection with the larval stage of Echinococcus multilocularis and a major challenge to human public health. Vaccines are the most effective way to prevent and control infectious diseases. We previously revealed that the Echinocuccus granulosus recombinant protein P29 is a good vaccine candidate against E . granulosus . However, the protective and immunological mechanism of rEg.P29 against E . multilocularis remain unclear. In this study, CD4 + T cell-deficient mice are transferred with spleen CD4 + T cells isolated from wild-type mice and subjected to rEg...
December 28, 2023: Acta Biochimica et Biophysica Sinica
https://read.qxmd.com/read/38139439/elevated-cd39-t-regulatory-cells-and-reduced-levels-of-adenosine-indicate-a-role-for-tolerogenic-signals-in-the-progression-from-moderate-to-severe-covid-19
#30
JOURNAL ARTICLE
Alaa Elsaghir, Ehsan M W El-Sabaa, Asmaa M Zahran, Sahar A Mandour, Eman H Salama, Sahar Aboulfotuh, Reham M El-Morshedy, Stefania Tocci, Ahmed Mohamed Mandour, Wael Esmat Ali, Lobna Abdel-Wahid, Ibrahim M Sayed, Mohamed A El-Mokhtar
Viral infections trigger inflammation by controlling ATP release. CD39 ectoenzymes hydrolyze ATP/ADP to AMP, which is converted by CD73 into anti-inflammatory adenosine (ADO). ADO is an anti-inflammatory and immunosuppressant molecule which can enhance viral persistence and severity. The CD39-CD73-adenosine axis contributes to the immunosuppressive T-reg microenvironment and may affect COVID-19 disease progression. Here, we investigated the link between CD39 expression, mostly on T-regs, and levels of CD73, adenosine, and adenosine receptors with COVID-19 severity and progression...
December 18, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/38132355/influence-of-breast-cancer-extracellular-vesicles-on-immune-cell-activation-a-pilot-study
#31
JOURNAL ARTICLE
Jessie Santoro, Barbara Carrese, Maria Sara Peluso, Luigi Coppola, Massimiliano D'Aiuto, Gennaro Mossetti, Marco Salvatore, Giovanni Smaldone
Breast cancer is the leading cause of cancer-related death in women worldwide. It is well known that breast cancer shows significant alterations in the tumor microenvironment (TME), which is composed of a variety of immune cells, including natural killer (NK) cells, that have a key role in tumor development or anti-tumor responses in breast cancer patients. Luminal B (BT474) and triple-negative breast cancer (HS578T) cell lines were cultured in 2D and 3D model systems. PMBCs from healthy donors were isolated and treated with extracellular vesicles (EVs) from monolayer and spheroids of BT474 and HS578T and analyzed using cytofluorimetric approaches...
December 15, 2023: Biology
https://read.qxmd.com/read/38123369/chimeric-antigen-receptor-t-reg-therapy-in-transplantation
#32
REVIEW
Siawosh K Eskandari, Andrea Daccache, Jamil R Azzi
In the quest for more precise and effective organ transplantation therapies, chimeric antigen receptor (CAR) regulatory T cell (Treg ) therapies represent a potential cutting-edge advance. This review comprehensively analyses CAR Tregs and how they may address important drawbacks of polyclonal Tregs and conventional immunosuppressants. We examine a growing body of preclinical findings of CAR Treg therapy in transplantation, discuss CAR Treg design specifics, and explore established and attractive new targets in transplantation...
December 19, 2023: Trends in Immunology
https://read.qxmd.com/read/38106151/genomic-and-immune-determinants-of-resistance-to-anti-cd38-monoclonal-antibody-based-therapy-in-relapsed-refractory-multiple-myeloma
#33
Bachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, Giuseppe Bertuglia, Elona Saraci, Stefania Oliva, Elisa Genuardi, Marios Papadimitriou, Benjamin Diamond, Paolo Corradini, David Coffey, Ola Landgren, Niccolò Bolli, Benedetto Bruno, Mario Boccadoro, Massimo Massaia, Francesco Maura, Alessandra Larocca
Anti-CD38 antibody therapies have transformed multiple myeloma (MM) treatment. However, a large fraction of patients inevitably relapses. To understand this, we investigated 32 relapsed MM patients treated with daratumumab, lenalidomide, and dexamethasone (Dara-Rd; NCT03848676 ). Whole genome sequencing (WGS) before and after treatment pinpointed genomic drivers associated with early progression, including RPL5 loss and APOBEC mutagenesis. Flow cytometry on 202 blood samples, collected every three months until progression for 31 patients, revealed distinct immune changes significantly impacting clinical outcomes...
December 4, 2023: medRxiv
https://read.qxmd.com/read/38100544/acquisition-of-suppressive-function-by-conventional-t-cells-limits-antitumor-immunity-upon-t-reg-depletion
#34
JOURNAL ARTICLE
Sarah K Whiteside, Francis M Grant, Giorgia Alvisi, James Clarke, Leqi Tang, Charlotte J Imianowski, Baojie Zhang, Alexander C Evans, Alexander J Wesolowski, Alberto G Conti, Jie Yang, Sarah N Lauder, Mathew Clement, Ian R Humphreys, James Dooley, Oliver Burton, Adrian Liston, Marco Alloisio, Emanuele Voulaz, Jean Langhorne, Klaus Okkenhaug, Enrico Lugli, Rahul Roychoudhuri
Regulatory T (Treg ) cells contribute to immune homeostasis but suppress immune responses to cancer. Strategies to disrupt Treg cell-mediated cancer immunosuppression have been met with limited clinical success, but the underlying mechanisms for treatment failure are poorly understood. By modeling Treg cell-targeted immunotherapy in mice, we find that CD4+ Foxp3- conventional T (Tconv ) cells acquire suppressive function upon depletion of Foxp3+ Treg cells, limiting therapeutic efficacy. Foxp3- Tconv cells within tumors adopt a Treg cell-like transcriptional profile upon ablation of Treg cells and acquire the ability to suppress T cell activation and proliferation ex vivo...
December 15, 2023: Science Immunology
https://read.qxmd.com/read/38091833/neoadjuvant-chemotherapy-is-linked-to-an-amended-anti-tumorigenic-microenvironment-in-gastric-cancer
#35
JOURNAL ARTICLE
Xiangkun Huan, Kun Zou, Peichan Zhang, Haihua Ding, Chunyang Luo, Chunjie Xiang, Shuo Xu, Yuwen Zhuang, Cunen Wu, Yaohui Wang, Xiaoyu Wu, Che Chen, Junfeng Zhang, Xuequan Yao, Fukun Liu, Shenlin Liu, Zhenfeng Wu
BACKGROUND: Neoadjuvant chemotherapy (NAC) is a frequently intervention for patients with locally advanced gastric cancer (GC). Nevertheless, its impact on the tumor immune microenvironment remains unclear. METHODS: We used immunohistochemistry to identify T-cell subpopulations, tumor-associated neutrophils (TANs), and tumor-associated macrophages (TAMs) in the GC microenvironment (GCME) among paired samples (pre-chemotherapy and post-chemotherapy) from 48 NAC-treated patients...
December 12, 2023: International Immunopharmacology
https://read.qxmd.com/read/38091578/single-center-randomized-trial-of-t-reg-graft-alone-versus-t-reg-graft-plus-tacrolimus-for-the-prevention-of-acute-gvhd
#36
JOURNAL ARTICLE
Cameron S Bader, Anna Pavlova, Robert Lowsky, Lori Muffly, Parveen Shiraz, Sally Arai, Laura J Johnston, Andrew R Rezvani, Wen-Kai Weng, David B Miklos, Matthew J Frank, John S Tamaresis, Vaibhav Agrawal, Sushma Bharadwaj, Surbhi Sidana, Judith A Shizuru, Nathaniel B Fernhoff, Amy Putnam, Scott Killian, Bryan J Xie, Robert S Negrin, Everett Meyer
Allogeneic hematopoietic cell transplantation (HCT) is a curative therapy for hematological malignancies for which graft-versus-host disease (GVHD) remains a major complication. The use of donor T regulatory cells (Tregs) to prevent GVHD appears promising, including in our previous evaluation of an engineered graft product (T-reg graft) consisting of the timed, sequential infusion of CD34+ hematopoietic stem cells and high-purity Tregs followed by conventional T cells. However, whether immunosuppressive prophylaxis can be removed from this protocol remains unclear...
December 13, 2023: Blood Advances
https://read.qxmd.com/read/38063125/the-expression-levels-of-virulence-and-antibiotic-resistance-genes-in-lactococcus-garvieae-exposed-to-different-conditions
#37
JOURNAL ARTICLE
Şükrü Önalan, Dilara Hande Barlık
Lactococcus garvieae, balıkların hemorajik septisemisi olan laktokokkozun etken maddesidir. Laktokkoz, ticari açıdan önemli birçok tatlı su ve deniz türünü etkilediği için su ürünleri yetiştiriciliğinde önemli ekonomik kayıplara neden olur. Bu çalışmada çalışmada kullanılan bakterilerin biyokimyasal testlerde %92,5 oranında tespit edildiği görülmüştür...
November 30, 2023: Cellular and Molecular Biology
https://read.qxmd.com/read/38062135/oleic-acid-availability-impacts-thymocyte-preprogramming-and-subsequent-peripheral-t-reg-cell-differentiation
#38
JOURNAL ARTICLE
Liangyu Lin, Mingyuan Hu, Qing Li, Liming Du, Li Lin, Yueqing Xue, Fanjun Zheng, Fei Wang, Keli Liu, Yu Wang, Jiayin Ye, Xu Jiang, Xuefeng Wang, Jiaqi Wang, Jingjie Zhai, Benming Liu, Hongzhen Xie, Yanqin You, Jinyong Wang, Xiangyin Kong, Dechun Feng, Douglas R Green, Yufang Shi, Ying Wang
The nature of activation signals is essential in determining T cell subset differentiation; however, the features that determine T cell subset preference acquired during intrathymic development remain elusive. Here we show that naive CD4+ T cells generated in the mouse thymic microenvironment lacking Scd1, encoding the enzyme catalyzing oleic acid (OA) production, exhibit enhanced regulatory T (Treg ) cell differentiation and attenuated development of experimental autoimmune encephalomyelitis. Scd1 deletion in K14+ thymic epithelia recapitulated the enhanced Treg cell differentiation phenotype of Scd1-deficient mice...
January 2024: Nature Immunology
https://read.qxmd.com/read/38059621/effect-of-intralymphatic-allergen-specific-immunotherapy-on-house-dust-mite-in-a-murine-model-of-allergic-rhinitis
#39
JOURNAL ARTICLE
Joo Hyun Jung, Kyeong Ah Kim, Yun Sook Choi, Seon Tae Kim
BACKGROUND: Intralymphatic immunotherapy (ILIT) is a promising alternative for the treatment of patients with allergic rhinitis, providing similar therapeutic efficacy to conventional allergen-specific immunotherapy (AIT). However, the allergic mechanism of ILIT is not completely known. AIM: The aim of this study was to determine the efficacy of ILIT in a house dust mite (HDM) mouse model of allergic rhinitis. METHODS: BALB/c mice were divided into four groups: G1, control without allergy; G2, allergy sensitized with HDM; G3, allergy with ILIT (starting with HDM 1...
December 7, 2023: Acta Oto-laryngologica
https://read.qxmd.com/read/38047297/emerging-mrna-therapies-for-cardiac-fibrosis
#40
EDITORIAL
Blake Jardin, Jonathan A Epstein
Cardiac fibrosis remains an unmet clinical need that has so far proven difficult to eliminate using current therapies. As such, novel technologies are needed that can target the pathologic fibroblasts responsible for fibrosis and adverse tissue remodeling. mRNA encapsulated in lipid nanoparticles (LNPs) are an emerging technology that could offer a solution to this problem. Indeed, this strategy has already shown clinical success with the mRNA COVID-19 vaccines. In this AJP perspective, we discuss how this technology can be leveraged to specifically target cardiac fibrosis via several complementary strategies...
December 4, 2023: American Journal of Physiology. Cell Physiology
keyword
keyword
52421
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.